Compugen (CGEN) Stock Forecast
Compuen
AI forecast: CGEN
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Price over the last 6 months
CGEN: score, valuation and dividends
AI-Stock Invest describes the company by published rules: its Smart Score against peers, valuation against the sector, dividend history checked across sources, and red flags. The same for every reader — information, not a forecast and not advice.
Open in AI-Stock Invest → CGEN valuation vs sectorPremium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Forecast track record
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumAbout This Company
Compugen Ltd. is engaged in the research, development, and distribution of targeted and therapeutic drugs. The company’s portfolio primarily consists of early-stage and preclinical immuno-oncology programs aimed at developing cancer immunotherapies, both as monotherapies and in combination with other drugs. The company is also developing treatments for autoimmune diseases.
